Home / Pharmaceuticals / Travel Vaccines Market By Type (Routine Vaccination, Recommended Vaccination, Required Vaccination) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Travel Vaccines Market By Type (Routine Vaccination, Recommended Vaccination, Required Vaccination) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Published: Oct 2018 | Report Code: 59416-10-18

Industry Outlook

The travel vaccines market is set to reach US$ 6,886.7 Mn by 2026 from US$ 3,592.1 Mn in 2017 showcasing steady growth at a compounded annual growth rate (CAGR) of 7.5% during the forecast period from 2018 to 2026. As per the research findings of World Tourism Organization (WTO) the number of international arrivals throughout the globe is expected to reach 1.6 billion by 2020. It is estimated that 51% of these travelers accounted for holiday and recreational purpose, 15% tourist traveled for business purpose and 24% reported travel for religious reason and pilgrimage.

Travelers are at a high risk to bacterial and viral infection due to sudden change in humidity, altitude, temperature, poor hygiene and lack of medical services in remote areas etc. The World Health Organization (WHO) has drafted a treatment guideline for the travelers primarily focusing on the importance of vaccination as a preventive measure classified as routine, recommended and required vaccination.

Market Synopsis

Travel Vaccines Market

Get a sample copy for more information

"Required vaccination are gaining prominence due to sudden outbreak of fatal diseases such as ebola, zika and middle east respiratory syndrome"

Routine vaccination holds the largest market share by type in the travel vaccines market. It is helpful in developing immunity in humans against infectious diseases such as influenza, MMR, tuberculosis and diphtheria etc. The other factors responsible for the dominance of routine vaccination are the rising prevalence of infectious diseases and proactive government policies to promote vaccination in all age groups. Favorable reimbursement scenario has a positive impact on the routine vaccination market growth. Recommended vaccination are gaining popularity on account of facts such as increasing number of visitors globally. They are taken two months in advance on physicians recommendation to build immunity against endemic diseases such as cholera, diarrhea, Japanese encephalitis etc. Required vaccination will be the fastest growing segment on account of factors such as sudden outbreak of fatal diseases such as ebola, zika, malaria and middle east respiratory syndrome.

Travel Vaccines Market

Get a sample copy for more information

"Increasing public health awareness and well-developed healthcare infrastructure to drive North America market growth"

North America is the clear leader in travel vaccines market. The key parameters which propel the travel vaccines market growth in North America are increasing public health awareness and existence of well-developed healthcare infrastructure. Presence of key players and implementation of treatment guidelines emphasizing preventive care in citizens travelling abroad drive the North America market. European medical agency has made it mandatory for visitors to get vaccinated at the port of entry for infectious diseases such as tuberculosis, swine flu and hepatitis B etc. Asia Pacific will be showcasing fastest growth during the forecast period owing to rising prevalence of infectious diseases and rampant growth in tourism sector. Middle East and Africa performs stringent vaccination of the haj piligrims in order to prevent the spread of middle east respiratory syndrome (MERS). Since the outbreak of fatal diseases such as ebola and zika the healthcare agencies in Latin America and African region the government healthcare bodies have invested huge funds in developing vaccines to protect the health of their citizens.

Travel Vaccines Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Organic and inorganic market growth analysis were employed to determine the market estimation and compounded annual growth rate. The travel vaccines market segmentation comprises of by type and by geography.

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 By Type (2016–2026; US$ Mn)
 • Routine Vaccination
    o Hepatitis B
    o Influenza
    o MMR
    o Tuberculosis
    o Others
 • Recommended Vaccination
    o Cholera
    o Japanese Encephalitis
    o Diarrhea
    o Yellow Fever
    o Others
 • Required Vaccination
    o Malaria
    o Ebola
    o Zika
    o Middle East Respiratory Syndrome
    o Others

 Geography Segment (2016–2026; US$ Mn)
 • North America (United States and Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Market assessment is performed in the scope of report to understand the latest market trends prevailing in the travel vaccines market. Comprehensive study was performed to understand the disease etiology of different infections encountered by travelers throughout the globe and the preventive action taken by the global healthcare agencies. Competitive landscape is covered in the scope of the report to understand the competition existing among key players. The vaccines classified as routine, recommended and required vaccination are covered under the product portfolio segment. Major players providing travel vaccines are Baxter AG, Bharat Biotech, GlaxoSmithkline, Plc., Inovio Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, PaxVax Corporation, Sanofi Pasteur SA, Valneva SE and VBI Vaccines, Inc.

Key questions answered in this report

  • What is the market estimation and compounded annual growth rate for travel vaccines market?
  • Who are the major players in travel vaccines market?
  • What are the treatment guidelines and vaccination prescribed by regulatory bodies throughout the globe?
  • What are the drivers, challenges and opportunities existing in the travel vaccines market?
  • What is the competitive scenario existing in travel vaccines market?
  • Which is the leading and fastest growing type segment for travel vaccines market?
  • Which is the leading and fastest growing regional segment for travel vaccines market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global TV MarketTV Market Portraiture
2.2. Global TV MarketTV Market, by Type, 2017 (US$ Mn)
2.3. Global TV MarketTV Market, by Geography, 2017 (US$ Mn)

Chapter 3. Travel Vaccine (TV) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global TV MarketTV Market, by Key Players, 2017

Chapter 4. Global Travel Vaccine (TV) Market, by Type
4.1. Overview
4.2. Routine Vaccination
4.2.1. Hepatitis B
4.2.2. Influenza
4.2.3. MMR
4.2.4. Tuberculosis
4.2.5. Others
4.3. Recommended Vaccination
4.3.1. Cholera
4.3.2. Japanese Encephalitis
4.3.3. Diarrhea
4.3.4. Yellow Fever
4.3.5. Others
4.4. Required Vaccination
4.4.1. Malaria
4.4.2. Ebola
4.4.3. Zika
4.4.4. Middle East Respiratory Syndrome
4.4.5. Others

Chapter 5. Global Travel Vaccine (TV) Market, by Geography
5.1. Overview
5.2. North America TV MarketTV Market Analysis, 2016 – 2026
5.2.1. North America TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.2.2. North America TV MarketTV Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe TV MarketTV Market Analysis, 2016 – 2026
5.3.1. Europe TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific TV MarketTV Market Analysis, 2016 – 2026
5.4.1. Asia Pacific TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America TV MarketTV Market Analysis, 2016 – 2026
5.5.1. Latin America TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East and Africa TV MarketTV Market Analysis, 2016 – 2026
5.6.1. MEA TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Baxter AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Type Portfolio
6.1.4. News Coverage
6.2. Bharat Biotech
6.3. GlaxoSmithkline, Plc.
6.4. Inovio Pharmaceuticals, Inc.
6.5. Merck & Co., Inc.
6.6. Novartis AG
6.7. PaxVax Corporation
6.8. Sanofi Pasteur SA
6.9. Valneva SE
6.10. VBI Vaccines, Inc.

* TVTravel Vaccine

FIG. 1 Travel Vaccine (TV) Market: Research Methodology
FIG. 2 TV Market Segmentation
FIG. 3 Global TV Market, by Type, 2017 (US$ Mn)
FIG. 4 Global TV Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global TV Market, by Key Players, 2017
FIG. 7 Global Hepatitis B TV Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Influenza TV Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global MMR TV Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Tuberculosis TV Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Other Routine TV Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Cholera TV Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Japanese Encephalitis TV Market, 2016 – 2026 (US$ Mn)
FIG. 14 Global Diarrhea TV Market, 2016 – 2026 (US$ Mn)
FIG. 15 Global Yellow Fever TV Market, 2016 – 2026 (US$ Mn)
FIG. 16 Global Other Recommended TV Market, 2016 – 2026 (US$ Mn)
FIG. 17 Global Malaria TV Market, 2016 – 2026 (US$ Mn)
FIG. 18 Global Ebola TV Market, 2016 – 2026 (US$ Mn)
FIG. 19 Global Zika TV Market, 2016 – 2026 (US$ Mn)
FIG. 20 Global Middle East Respiratory Syndrome TV Market, 2016 – 2026 (US$ Mn)
FIG. 21 Global Other Required TV Market, 2016 – 2026 (US$ Mn)
FIG. 22 U.S. TV Market, 2016 – 2026 (US$ Mn)
FIG. 23 Canada TV Market, 2016 – 2026 (US$ Mn)
FIG. 24 U.K. TV Market, 2016 – 2026 (US$ Mn)
FIG. 25 Germany TV Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of Europe TV Market, 2016 – 2026 (US$ Mn)
FIG. 27 China TV Market, 2016 – 2026 (US$ Mn)
FIG. 28 Japan TV Market, 2016 – 2026 (US$ Mn)
FIG. 29 Rest of Asia Pacific TV Market, 2016 – 2026 (US$ Mn)
FIG. 30 Brazil TV Market, 2016 – 2026 (US$ Mn)
FIG. 31 Mexico TV Market, 2016 – 2026 (US$ Mn)
FIG. 32 Rest of Latin America TV Market, 2016 – 2026 (US$ Mn)
FIG. 33 GCC TV Market, 2016 – 2026 (US$ Mn)
FIG. 34 Rest of MEA TV Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Travel Vaccine (TV) Market Portraiture
TABLE 2 Global TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Routine TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Recommended TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Required TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global TV Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America TV Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Europe TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East and Africa TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Baxter AG: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 18 Bharat Biotech: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 19 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 20 Inovio Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 21 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 22 Novartis AG.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 23 PaxVax Corporation: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 24 Sanofi Pasteur SA: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 25 Valneva SE: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 26 VBI Vaccines, Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients